Table I.
Methods - Patients, diagnostic/predictive tests and staining.
| Items | Overall (N) | NSCLC (N) |
|---|---|---|
| Patients | 39,357 | 421 |
| Tissue samples | 58,530 | 724 |
| Surgery specimen | 149 | |
| Biopsy | 247 | |
| Citology | 178 | |
| Liquid biopsy | 150 | |
| Blocks | 102,008 | 2537 |
| Surgery specimen | 2162 | |
| Biopsy | 247 | |
| Citology | 128 | |
| Slides | 222,440 | 5120 |
| H&E | 3351 | |
| Surgery specimen | 2601 | |
| Biopsy | 459 | |
| Citology | 291 | |
| Diagnostic IHC a | 720 | |
| Surgery specimens | 253 | |
| Biopsy | 395 | |
| Citology | 72 | |
| Predictive IHC b | 1049 | |
| Surgery specimen | 345 | |
| Biopsy | 595 | |
| Citology | 109 | |
| Staining | 2 | |
| Special staining | 2 | |
| Molecular Tests | 582 | |
| FISH | 155 | |
| NGS | 103 | |
| RealTime PCR | 323 |
a The following diagnostic IHC tests were performed (mean volumes between brackets): TTF-1(192); p40/p63(192); CK5/6(83); CK7(117); Napsin A (86); Synaptophysin (33); INSM1(17).
b The following predictive IHC tests were performed (mean volumes between brackets): ALK (273); BRAF (46); EGFR (183); ROS1(165); HER2(23); NTRK (17); MET (17); RET (18); PD-L1(307).